Accéder au contenu
Merck

Long-term high-dose vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial.

Hypertension (Dallas, Tex. : 1979) (2014-07-02)
Robert Scragg, Sandy Slow, Alistair W Stewart, Lance C Jennings, Stephen T Chambers, Patricia C Priest, Christopher M Florkowski, Carlos A Camargo, David R Murdoch
RÉSUMÉ

Previous randomized controlled trials of vitamin D supplementation and blood pressure (BP) mainly have given vitamin D for short periods (<6 months) or at low doses (400 IU per day). This study aims to determine whether long-term high-dose vitamin D taken for 18 months lowers BP. Adults were recruited from a healthcare organization or university into a double-blind controlled trial and randomized to receive either vitamin D3 200 000 IU for 2 months followed by 100 000 IU monthly up to 18 months (n=161) or placebo (n=161). BP was measured at baseline, 5, and 18 months. Subjects had a mean (SD) age of 47.6 (9.7) years, 75% were women, and 94% were of European ancestry (white). Mean (SD) 25-hydroxyvitamin D3 changed from 73 (22) nmol/L at baseline to 124 (28) nmol/L at 18 months in the vitamin D group, and from 71 (22) nmol/L to 56 (22) nmol/L in the placebo group. Mean BP was similar for the vitamin D and placebo groups at baseline (123.4/76.3 versus 122.6/75.6 mm Hg; respectively). The mean change (95% confidence interval) in BP at 18 months minus baseline in the vitamin D group compared with placebo group was -0.6 (-2.8 to 1.6) mm Hg for systolic (P=0.61) and 0.5 (-1.1, 2.2) mm Hg for diastolic (P=0.53). Long-term vitamin D supplementation, which increased mean 25-hydroxyvitamin D3 concentration >100 nmol/L for 18 months, had no effect on systolic or diastolic BP in predominantly white, healthy adults without severe vitamin D deficiency. Beneficial effects on BP cannot be ruled out for other populations.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Cholécalciférol, ≥98% (HPLC)
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Cholecalciferol (D3), analytical standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
USP
Cholécalciférol, United States Pharmacopeia (USP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Supelco
Cholécalciférol (vitamine D3), Pharmaceutical Secondary Standard; Certified Reference Material
Référence
Conditionnement
Disponibilité
Prix
Quantité
Cholécalciférol, European Pharmacopoeia (EP) Reference Standard
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Cholécalciférol, meets USP testing specifications
Référence
Conditionnement
Disponibilité
Prix
Quantité
Sigma-Aldrich
Cholécalciférol, analytical standard
Référence
Conditionnement
Disponibilité
Prix
Quantité